Thrombolytic therapy, infarct vessel patency and late potentials: can the arrhythmic substrate be altered?
Winters
S L
SL
Division of Cardiology, Mount Sinai School of Medicine, New York, New York 10029.
Gomes
J A
JA
D001145:Arrhythmias, Cardiac / Q000209:etiology / Q000517:prevention & control*; D004562:Electrocardiography / Q000379:methods; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D009203:Myocardial Infarction / Q000150:complications* / Q000188:drug therapy; D014654:Vascular Patency / Q000187:drug effects*
D005343:Fibrinolytic Agents